• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性球形红细胞增多症中的视网膜中央静脉阻塞

CENTRAL RETINAL VEIN OCCLUSION IN HEREDITARY SPHEROCYTOSIS.

作者信息

Huggins Alison B, Garg Sunir J, Sando Ralph S

机构信息

*MidAtlantic Retina, The Retina Service of Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania; and †Accuvision Eye M.D. Caregroup, The Cataract and Primary Eye Care Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.

出版信息

Retin Cases Brief Rep. 2015 Nov 13. doi: 10.1097/ICB.0000000000000247.

DOI:10.1097/ICB.0000000000000247
PMID:26579593
Abstract

PURPOSE

To investigate and identify hereditary spherocytosis as a possible risk factor for the development of a central retinal vein occlusion in a young, otherwise healthy, adult.

METHOD

This study is a retrospective case description of a single female patient.

RESULTS

A 31-year-old white woman with hereditary spherocytosis after splenectomy was found to have a central retinal vein occlusion. She had no atherosclerotic risk factors and a negative hypercoaguable workup. Her course was complicated by macular edema. She was treated with intravitreal ranibizumab injections with resultant improvement of her vision and resolution of her macular edema.

CONCLUSION

Hereditary spherocytosis is an inherited deficiency in erythrocyte membrane proteins that should be considered in younger patients with central retinal vein occlusions because of the disease's impact on hematologic factors. Furthermore, intravitreal antivascular endothelial growth factor injections may improve macular edema in this population.

摘要

目的

调查并确定遗传性球形红细胞增多症是否为年轻、健康成年人群发生视网膜中央静脉阻塞的潜在危险因素。

方法

本研究是对一名女性患者的回顾性病例描述。

结果

一名31岁行脾切除术后的患有遗传性球形红细胞增多症的白人女性被发现患有视网膜中央静脉阻塞。她没有动脉粥样硬化危险因素,且高凝检查结果为阴性。她的病程因黄斑水肿而复杂化。她接受了玻璃体内注射雷珠单抗治疗,视力得到改善,黄斑水肿消退。

结论

遗传性球形红细胞增多症是一种红细胞膜蛋白的遗传性缺陷,鉴于该疾病对血液学因素的影响,对于患有视网膜中央静脉阻塞的年轻患者应考虑这一因素。此外,玻璃体内注射抗血管内皮生长因子可能改善该人群的黄斑水肿。

相似文献

1
CENTRAL RETINAL VEIN OCCLUSION IN HEREDITARY SPHEROCYTOSIS.遗传性球形红细胞增多症中的视网膜中央静脉阻塞
Retin Cases Brief Rep. 2015 Nov 13. doi: 10.1097/ICB.0000000000000247.
2
Consecutive central and branch retinal vein occlusions in the same eye of a young healthy COVID-19 patient: A unique case report.一名年轻健康的新冠肺炎患者同一只眼睛先后发生视网膜中央静脉阻塞和视网膜分支静脉阻塞:一例独特病例报告。
Am J Ophthalmol Case Rep. 2022 Jul 31;27:101669. doi: 10.1016/j.ajoc.2022.101669. eCollection 2022 Sep.
3
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.玻璃体内雷珠单抗与阿柏西普和贝伐珠单抗治疗视网膜中央静脉阻塞所致黄斑水肿的比较:LEAVO 非劣效性三臂 RCT。
Health Technol Assess. 2021 Jun;25(38):1-196. doi: 10.3310/hta25380.
4
Change of cytokines after intravitreal ranibizumab in patients with recurrent branch retinal vein occlusion and macular edema.玻璃体内注射雷珠单抗后复发性视网膜分支静脉阻塞伴黄斑水肿患者细胞因子的变化。
Eur J Ophthalmol. 2021 Jan;31(1):204-210. doi: 10.1177/1120672119885054. Epub 2019 Nov 5.
5
CENTRAL RETINAL VEIN OCCLUSION WITH SEVERE MACULAR EDEMA IN EARLY PREGNANCY.妊娠早期伴严重黄斑水肿的中央视网膜静脉阻塞。
Retin Cases Brief Rep. 2022 Sep 1;16(5):547-549. doi: 10.1097/ICB.0000000000001063.
6
RELATIONSHIP BETWEEN CHOROIDAL FINDINGS AND GROWTH FACTORS, CYTOKINES, AND OTHER INFLAMMATORY MEDIATORS AFTER INTRAVITREAL RANIBIZUMAB INJECTION IN PATIENTS WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION.脉络膜病变与眼内注射雷珠单抗后生长因子、细胞因子及其他炎症介质的关系:继发于分支视网膜静脉阻塞的黄斑水肿患者
Retina. 2022 Apr 1;42(4):744-751. doi: 10.1097/IAE.0000000000003362.
7
Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.雷珠单抗与地塞米松植入物治疗视网膜分支静脉阻塞继发黄斑水肿的两年疗效
Optom Vis Sci. 2018 Dec;95(12):1149-1154. doi: 10.1097/OPX.0000000000001306.
8
The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion.在缺血性中央静脉阻塞继发黄斑水肿的难治性病例中,将雷珠单抗换用阿柏西普的效果。
Klin Monbl Augenheilkd. 2015 Apr;232(4):552-5. doi: 10.1055/s-0035-1545783. Epub 2015 Apr 22.
9
[Bevacizumab and Ranibizumab for macular edema due to retinal vein occlusions].贝伐单抗和雷珠单抗治疗视网膜静脉阻塞所致黄斑水肿
Klin Monbl Augenheilkd. 2013 Apr;230(4):405-8. doi: 10.1055/s-0032-1328373. Epub 2013 Apr 29.
10
Rapid resolution of macular edema associated with central retinal vein occlusion using ranibizumab after failure with multiple bevacizumab injections.在多次注射贝伐单抗治疗失败后,使用雷珠单抗使与视网膜中央静脉阻塞相关的黄斑水肿迅速消退。
Semin Ophthalmol. 2011 Nov;26(6):387-91. doi: 10.3109/08820538.2011.622339.

引用本文的文献

1
Angioid streaks in hereditary spherocytosis associated with an SPTB gene variant.与SPTB基因变异相关的遗传性球形红细胞增多症中的血管样条纹。
Doc Ophthalmol. 2025 Jul 9. doi: 10.1007/s10633-025-10039-w.
2
Clinical Features of Central Retinal Vein Occlusion in Young Patients.年轻患者中心性视网膜静脉阻塞的临床特征
Ophthalmol Ther. 2022 Aug;11(4):1409-1422. doi: 10.1007/s40123-022-00534-7. Epub 2022 Jun 13.
3
Bilateral macular hemorrhage in a patient with COVID-19.一名新冠肺炎患者出现双侧黄斑出血。
Am J Ophthalmol Case Rep. 2020 Dec;20:100958. doi: 10.1016/j.ajoc.2020.100958. Epub 2020 Oct 9.